Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders. The Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-prenatal-and-newborn-genetic-testing-2015-2019-market
Big Market Research present “Global Gaucher Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-gaucher-disease-2015-2019-market Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow.
Big Market Research present “Global Genetic Testing Market Outlook” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, and Forecast. Visit for more info @ http://www.bigmarketresearch.com/global-genetic-testing-outlook-2015-2022-market The Global Genetic Testing Market accounted for $3.2 billion in 2014 and is expected to grow at a CAGR of 9.26% to reach $6.5 billion by 2022. The factors contributing to the market growth include aging population, growing awareness, availability of direct to consumer tests and increasing incidence of genetic disorder. However factors such as high cost for testing and reimbursement issues are inhibiting the growth of the market.
The genome is the genetic material of an individual, species or organism, which is responsible for the various functional characteristics of an individual. Genomics is an important aspect of genetics and molecular biology that focuses on the study of the structure, function, and mapping of genomes. It involves various applications in functional genomics, genome sequencing, comparative genomics, and genome analysis. A defect in genome structure or function could lead to the occurrence of disorders. Read more details at: http://www.bigmarketresearch.com/genomics-in-the-us-2014-2018-market
Cystic fibrosis also known as mucoviscidosis is a genetically-inherited disease. It is one of the most common genetic disorders found in the Caucasian children. The incidence of cystic fibrosis varies among populations, and is substantially less common in Asian and African populations as compared to the people of Caucasoid origin of Europe and North America, with a marked difference within each country. Cystic fibrosis is a chronic disease. The production of a high-salt containing sweat and secretion of abnormal viscous mucus are the major symptoms of cystic fibrosis. Read more details at: http://www.bigmarketresearch.com/global-cystic-fibrosis-2015-2019-market
Big Market Research “Global Colorectal Cancer Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-colorectal-cancer-drugs-2015-2019-market Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US.
Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders.
Global Pompe Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pompe Disease market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Read more details at: http://www.bigmarketresearch.com/global-pompe-disease-2015-2019-market
Big Market Research presents a fresh survey on “Global Dairy Alternative Beverages Market 2015-2019” Report Copy Available @ http://www.bigmarketresearch.com/global-dairy-alternative-beverages-market Market outlook of dairy alternative drinks Market research analyst predicts the global dairy alternative drinks market to grow steadily at a CAGR of approximately 15% between 2015 and 2019. The nutritional benefits of dairy alternative drinks are the key growth drivers of this market. Dairy alternative drinks are plant-based milk made from cereals, nuts, and seeds. Health issues such as lactose intolerance, milk allergy, and the genetic disorder such as Phenylketonuria can be resolved by taking dairy alternative beverages as these are plant based milk and are free from animal proteins. Moreover, they have low-fat and low-cholesterol levels, making them a popular choice for health-conscious consumers and vegans.
Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities. Read more details @ http://www.bigmarketresearch.com/global-gaucher-disease-2015-2019-market
Research Beam added a report “Global Genetic Testing Market Outlook 2015 – 2022”. The Global Genetic Testing Market accounted for $3.2 billion in 2014 and is expected to grow at a CAGR of 9.26% to reach $6.5 billion by 2022. The factors contributing to the market growth include aging population, growing awareness, availability of direct to consumer tests and increasing incidence of genetic disorder. However factors such as high cost for testing and reimbursement issues are inhibiting the growth of the market. Genetic testing for cancer is likely to be the fastest growing segment during the forecast period. Increasing incidence of genetic diseases is providing more opportunities for genetic testing along with the rise in personalized medicine. To get details @ http://www.researchbeam.com/global-genetic-testing-outlook-2015-2022-market
UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases.
The global digital PCR (dPCR) and qPCR market has been segmented on the basis of type of technology (real-time PCR and digital PCR), type of product (instruments, reagents and consumables, and softwares and services), type of end-users (research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories) applications and type of application (research, clinical, and forensic applications). See Full Report : http://bit.ly/1FSGTym
Big Market Research has announced a new Report Package "Global Stem Cell Umbilical Cord Blood (UCB) Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/global-stem-cell-umbilical-cord-blood-ucb-2015-2019-market UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280090
Big Market Research has announced a new Report Package "Global miRNA Market -Size, Share, Trends, Forecast,Development, Situation, Future outlook, Potential" Get Complete Report At: http://www.bigmarketresearch.com/global-mirna-2015-2019-market miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study expression of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. Enquire For This Report At: http://www.bigmarketresearch.com/report-enquiry/150109
JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde
Big Market Research has announced a new Report Package "Global ADHD Drugs Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-adhd-drugs-2014-2018-market ADHD is a psychiatric disorder, which is mostly found in children. However, adults have also been reported to be diagnosed with ADHD. The patients with ADHD suffer from several problems including hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/144024
Big Market Research has announced a new Report Package "Global Acute Myeloid Leukemia Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia. Enquire At: http://www.bigmarketresearch.com/report-enquiry/169995
Big Market Research has announced a new Report Package "Global Huntington's Disease Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-huntingtons-disease-therapeutics-2014-2018-market Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically programmed degeneration of neurons in some parts of the brain such as basal ganglia and cerebral cortex. Enquire At: http://www.bigmarketresearch.com/report-enquiry/144058
The global psoriasis market was valued at about $30.13 billion in 2018 and is expected to grow to $46.57 billion at a CAGR of 11.5% through 2022. Read more at http://bit.ly/2FdI7ZJ
Enzymes have gathered a special attention in the recent years due to its potential application in the several industries such as food & animal feed, textiles and Surfactants, pharmaceuticals & biotechnology R&D and manufacturing and others (paper and pulp processing, leather processing and agriculture). For more information visit at: https://goo.gl/Mmyvc3
World Health Organization (WHO) suggests that over 50% of the worldwide population is obese. Furthermore, in the year 2014, over 1.9 billion adults that were 18 years and above were overweight. Out of these, more than 600 million were reported obese
Latest research report “Protein Expression Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2m6odJN Request a Sample: http://bit.ly/2kayLac
Latest research report “Pharmaceutical API Manufacturing Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2TRHdbJ Request a Sample: http://bit.ly/2NgKss1
Big Market Research adds a report “Preimplantation Genetic Diagnosis Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018" Know More @ http://www.bigmarketresearch.com/global-preimplantation-genetic-diagnosis-pgd-2014-2018-market This report covers the present scenario and the growth prospects of the Global Preimplantation Genetic Diagnosis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of PGD services and products including kits and instruments used for PGD. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/144085
The “Animal Genetics Market by Products (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material), by Testing services (DNA Sexing, DNA Typing, Genetic Disease Test, and Others) - Global Forecast to 2020”, The global animal genetics market is estimated to be worth around $2.5 billion in 2014 and grow at a CAGR of 8-9% during the forecast period of 2014 to 2020.
Big Market Research adds a report “Preimplantation Genetic Diagnosis Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018" Know More @ http://www.bigmarketresearch.com/global-preimplantation-genetic-diagnosis-pgd-2014-2018-market This report covers the present scenario and the growth prospects of the Global Preimplantation Genetic Diagnosis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of PGD services and products including kits and instruments used for PGD. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/144085
Paper Diagnostics Market size was valued at around USD 4 billion in 2015 with revenue forecast to exceed USD 8 billion by 2023. Get more details @ https://goo.gl/YdCa5Y
The “Animal Genetics Market by Products (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material), by Testing services (DNA Sexing, DNA Typing, Genetic Disease Test, and Others) - Global Forecast to 2020.
Enzymes Market | The increasing use of functional food and beverages (which contain enzymes), increasing demand for cellulosic and amylase biofuels along with effective pharmaceuticals & cosmetics, are some of the key factors that drive the growth of the global enzymes market during the analysis period. Furthermore, the increasing adoption of technology such as protein engineering is significantly fueling the demand for the enzyme market. Factors restraining the market growth are high sensitivity of enzymes to temperature and pH and risk of contamination.
Complete report on Hemophilia market spread across 86 pages providing 4 company profiles and 13 tables and 46 charts is now available at http://www.marketreportsonline.com/579011.html.
Big Market Research “Global Kidney Cancer Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-kidney-cancer-drugs-2015-2019-market Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders. This usually results in late stage detection of the disease, which leads to less chances of patient survival.
The cardiac pacemaker market has also faced numerous challenges in terms of increased competition because of rising number of organized and unorganized player in the market thus leading to competition in terms of price and thus negatively affecting the revenue.
Research Beam added a report on “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2015” Enquiry about report: http://www.researchbeam.com/glycogen-storage-disorders-gsd-global-clinical-trials-review-h2-2015-market/enquire-about-report
The global sports medicine market, a subset of the orthopedic market, has been on a rising trend largely supported by increased number of cases of sports injuries owing to a shift in the demographic trends towards the elderly population and changes in lifestyle mainly pertaining to the younger population. For More Details: http://goo.gl/lZAWi4
DelveInsights, Panic Disorders-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Panic Disorders.
Hemoglobinopathies Market size was valued at over USD 4 billion in 2015. High occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia is a major growth driver.
Hemoglobinopathies Market size was valued at over USD 4 billion in 2015. High occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia is a major growth driver.
On the basis of type of application, the global digital PCR and qPCR market is classified into research applications, clinical applications, and forensic applications
This report studies the global digital PCR (dPCR) and qPCR market over the forecast period of 2014 to 2019. The market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.
Big Market Research : World In-vitro Fertilization (IVF) Market - Size, Share, Trends, Demand, Report, Opportunities and Forecast 2021 To Get More Details @ http://www.bigmarketresearch.com/IVF-in-vitro-fertilization-service-market The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.
To Get sample Brochure now@ http://tinyurl.com/jv4yqfr A detailed qualitative analysis of the factors responsible for driving and restraining growth of the World Enzymes Market and future opportunities are provided in the report.
The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.
LVAD, Left Ventricular Assist Device, is a mechanical device that circulates blood throughout the body when the heart is too weak to pump blood on its own. They are used in the bridge-to-transplantation (BTT), destination therapy (DT) and bridge to recovery. For More Details: http://goo.gl/s2Y5g0
The global hemophilia market report provides a comprehensive study of global hemophilia market and also major regional markets. For more mail: vikas@konceptanalytics.com
IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry The market is poised to witness a remarkable growth, primarily due to the latest technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.
The report titled “Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)” provides. For details, write to info@daedal-research.com
The Global Thalassemia Market report provides a comprehensive study of global thalassemia market and also major regional markets. For more mail: vikas@konceptanalytics.com
The world over, the high obesity rate has become a burden, and the dire need to bring it under control has risen as a result. World Health Organization (WHO) suggests that over 50% of the worldwide population is obese. Furthermore, in the year 2014, over 1.9 billion adults that were 18 years and above were overweight.
RNA Based Therapeutics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the period 2014-2020.Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry.
Get a sample brochure @ http://tinyurl.com/gpltoss IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures. The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints.
The respiratory disorders market is forecast to rise from a value of $28.1 billion in 2015 to $46.6 billion in 2022, at a CAGR of 7.5%. To See Full Report @ http://bit.ly/2ggmcXp
The global e-clinical solution software market is witnessing significant growth due to increasing clinical trials and R&D investments in pharmaceuticals and life science sectors. Increasing prevalence of diseases across the world is leading to rise in number of clinical trials. Various lifestyle-associated diseases and genetic disorders in the Middle East and North Africa have also led to increase in clinical trials in the respective regions.